Deutsche Bank raised the firm’s price target on Cellebrite to $10 from $9 and keeps a Buy rating on the shares post the Q3 report. The company’s momentum continues with another beat and raise quarter, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLBT:
- Cellebrite appoints Jewell as Global CRO
- Cellebrite narrows FY23 revenue view to $315M-$320M from $310M-$320M
- Cellebrite reports Q3 adjusted EPS 9c, consensus 5c
- Cellebrite Continues Global Growth with Appointment of First Global Chief Revenue Officer, Marcus Jewell
- Cellebrite Announces Third-Quarter 2023 Results